Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

Relapse remains the main cause of treatment failure in acute myeloid leukemia (AML) undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT). Emerging evidence has demonstrated that AML patien...

Source: Journal of Hematology and Oncology - January 6, 2021 Category: Hematology Authors: Li Xuan and Qifa Liu Tags: Review Source Type: research